Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

By Sicklick Jason   Lopez Nicole  

Journal of Gastrointestinal Surgery, Vol. 17, Iss. 11, 2013-11 ,pp. : 1997-2006

Springer Publishing Company

Access to resources Recommend Favorite

Current Standard and Future Perspectives in the Treatment of Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 95, Iss. 4, 2017-04 ,pp. : 262-268

Karger

Access to resources Recommend Favorite

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

By Sawaki Akira   Yamao Kenji   Nakamura Tsuneya   Suzuki Takashi   Okubo Kenji   Hara Kazuo   Kawai Hiroki   Yamamura Yoshitaka   Ito Seiji   Mochiduki Yoshinari   Ohno Ryuzo  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Clinicopathological study of 113 gastrointestinal stromal tumors

By Bhalgami Rahul  

Indian Journal of Gastroenterology, Vol. 32, Iss. 1, 2013-01 ,pp. : 22-27

Springer Publishing Company

Access to resources Recommend Favorite